Antiestrogen therapy for breast cancer modifies the risk of subsequent cutaneous melanoma

Cancer Prevention Research

Volumn 5, Issue 1, 2012, Pages 82-88

  Huber, Caroline ^a   Bouchardy, Christine ^b   Schaffar, Robin ^b   Neyroud Caspar, Isabelle ^b   Vlastos, Georges ^a   Le Gal, Frédérique Anne ^a   Rapiti, Elisabetta ^b   Benhamou, Simone ^b,c,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b GENEVA CANCER REGISTRY   (Switzerland)

^c INSERM   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SKIN TUMOR; STANDARDIZED INCIDENCE RATIO;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; REGISTRIES; RISK; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84855544356     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0332     Document Type: Article

References (29)

1. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009;20:1-7.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008:GLOBOCAN2008. Int J Cancer 2010;127:2893-917.
3. Bandarchi B, Ma L, Navab R, Seth A, Rasty G. From melanocyte to metastatic malignant melanoma. Dermatol Res Pract 2010 (in press). doi: 10.1155/2010/583748.
4. Schmidt AN, Nanney LB, Boyd AS, King LE Jr, Ellis DL. Oestrogen receptor-beta expression in melanocytic lesions. Exp Dermatol 2006;15:971-80. (Pubitemid 44696115)
5. de Vries E, Nijsten TE, Visser O, Bastiaannet E, van HattemS, Janssen- Heijnen ML, et al. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. Ann Oncol 2008;19:583-9. (Pubitemid 351325683)
6. Joosse A, de Vries E, Eckel R, Nijsten T, Eggermont AM, Hölzel D, et al. Gender differences in melanoma survival: female patients have a decreased risk of metastasis. J Invest Dermatol 2011;131:719-26.
7. Ohata C, Tadokoro T, Itami S. Expression of estrogen receptor beta in normal skin, melanocytic nevi and malignant melanomas. J Dermatol 2008;35:215-21. (Pubitemid 351561712)
8. de Giorgi V, Mavilia C, Massi D, Gozzini A, Aragona P, Tanini A, et al. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohisto-chemical study. Arch Dermatol 2009;145:30-6.
9. Driscoll MS, Grant-Kels JM. Estrogen receptor expression in cutaneous melanoma. Arch Dermatol 2009;145:73-5.
10. Nading MA, Nanney LB, Ellis DL. Pregnancy and estrogen receptor beta expression in a large congenital nevus. Arch Dermatol 2009;145:691-4.
11. Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, et al. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer 2011;117:1288-95.
12. Cancer incidence in five continents, Vol IX. IARCScientific Publications no 160. Lyon, France: International Agency for Research on Cancer;2008.
13. Percy C, Fritz A, Jack A, Shanmugarathan S, Sobin L, Parkin DM, et al. ICD-O International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
14. Sobin LH, Wittekind CH, editors. TNM classification of malignant tumours, 6th ed. New York: UICC; 2002.
15. Ewertz M, Mouridsen HT. Second cancer following cancer of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr 1985;68:325-9. (Pubitemid 16233737)
16. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:99-112. (Pubitemid 16233726)
17. Volk N, Pompe-Kirn V. Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 1997;8:764-70. (Pubitemid 27404647)
18. Rubino C, de Vathaire F, Diallo I, Shamsaldin A, Le MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000;61:183-95. (Pubitemid 30609552)
19. Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, et al. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2002;52:406-14. (Pubitemid 34173002)
20. Goggins W, Gao W, Tsao H. Association between female breast cancer and cutaneous melanoma. Int J Cancer 2004;111:792-4. (Pubitemid 39062905)
21. Mellemkjaer L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006;118:2285-92.
22. Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A, et al. Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 2008;98:870-4. (Pubitemid 351341602)
23. Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol 2008;26:1239-46.
24. Rubino C, de Vathaire F, Shamsaldin A, Labbe M, Lê MG. Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer 2003;89:840-6. (Pubitemid 37175805)
25. Gupta A, Marcia S. Do hormones influence melanoma? Facts and controversies. Clin Dermatol 2010;28:287-92.
26. Driscoll MS, Grant-Kels JM. Hormones, nevi, and melanoma: an approach to the patient. J Am Acad Dermatol 2007;57:919-31. (Pubitemid 350087357)
27. Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control 2008;19:437-42.
28. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study. Ann Oncol 2009;20:358-64.
29. Kvaskoff M, Bijon A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. Am J Epidemiol 2001;173:1192-202.